FDA Recalls Trospium Chloride Extended-Release Capsules for Manufacturing Defect
Padagis US LLC is recalling Trospium Chloride Extended-Release Capsules (60 mg) due to manufacturing defects where some capsules contain missing, broken, or extra tablets. The recall affects 7,032 bottles distributed nationwide.
- Product
- TROSPIUM CHLORIDE — TROSPIUM CHLORIDE (TROSPIUM CHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide